Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity

Chinese Journal of Physiology

Volumn 54, Issue 6, 2011, Pages 399-405

  Guo, Hong ^a   Hu, Li Min ^a   Wang, Shao Xia ^a   Wang, Yu Lin ^a   Shi, Fang ^a   Li, Hui ^a   Liu, Yang ^a   Kang, Li Yuan ^a   Gao, Xiu Mei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Antioxidant capacity; Neuroprotective effects; Scutellarin

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SCUTELLARIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME REGULATION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT; TREATMENT DURATION;

EID: 84455171474     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM059     Document Type: Article

References (22)

1. Akpinar, D., Yargiçoǧlu, P., Derin, N., Alicigüzel, Y. and Aǧar, A. The effect of lipoic acid on antioxidant status and lipid peroxidation in rats exposed to chronic restraint stress. Physiol. Res. 57: 893-901, 2008.
2. Antonelli, T., Tomasini, M.C., Fournier, J., Mazza, R., Tanganelli, S., Pirondi, S., Fuxe, K. and Luca, F. Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation. Cereb. Cortex 18: 1748-1757, 2008.
3. Beck, J., Lenart, B., Kintner, D.B. and Sun, D. Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J. Neurosci. 23: 5061-5068, 2003.
4. Chan, P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21: 2-14, 2001.
5. Chandrashekhar, V.M., Ranpariya, V.L., Ganapaty, S., Parashar, A. and Muchandi, A.A. Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats. J. Ethnopharmacol. 127: 645-651, 2010.
6. Ding, R.F. and Li, Z.X. The clinical application of agents breviscapine. Tianjin Pharmacy 21: 60-63, 2009.
7. Domoki, F., Kis, B., Gáspár, T., Snipes, J.A., Parks, J.S., Bari, F. and Busija, D.W. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell Physiol. 296: 97-105, 2009.
8. Ga, S.R. and Wan, P. Progress in clinical application of breviscapine. Yunnan J. Tradi. Chinese Med. 30: 67-68, 2009.
9. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E. and Offen, D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54: 271-284, 2002.
10. Hu, X.M., Zhou, M.M., Hu, X.M. and Zeng, F.D. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol. Sin. 26: 1454-1459, 2005.
11. Imai, H., Masayasu, H. and Dewar, D. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32: 2149-2154, 2001.
12. Lin, Z., Zhu, D., Yan, Y., Yu, B., Wang, Q., Shen, P. and Ruan, K. An antioxidant phytotherapy to rescue neuronal oxidative stress. Evid-Based Complement Altern. Med. 2011: 1-7, 2008.
13. Liu, H., Yang, X.L., Wang, Y., Tang, X.Q., Jiang, D.Y. and Xu, H.B. Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. Acta Pharmacol. Sin. 24: 1113-1117, 2003.
14. Longa, E.Z., Weinstein, P.R., Carlson, S. and Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
15. Mao, P., Ardeshiri, A., Jacks, R., Yang, S., Hurn, P.D. and Alkayed, N.J. Mitochondrial mechanism of neuroprotection by CART. Eur. J. Neurosci. 26: 624-632, 2007.
16. Shen, C.C., Huang, H.M., Ou, H.C., Chen, H.L., Chen, W.C. and Jeng, K.C. Protective effect of nicotinamide on neuronal cells under oxygen and glucose deprivation and hypoxia/reoxygenation. J. Biomed. Sci. 11: 472-481, 2004.
17. Shi, H. and Liu, K.J. Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neurosci. Lett. 410: 57-61, 2006.
18. Xu, W., Zha, R.P., Wang, W.Y. and Wang, Y.P. Effects of scutellarin on PKCγ in PC12 cell injury induced by oxygen and glucose deprivation. Acta Pharmacol. Sin. 28: 1573-1579, 2007.
19. Ying, W. A new hypothesis of neurodegenerative diseases: the deleterious network hypothesis. Med. Hypotheses 47: 307-313, 1996.
20. Zhang, H.F., Hu, X.M., Wang, L.X., Xu, S.Q. and Zeng, F.D. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med. 75: 121-126, 2009.
21. Zhou, X.M., Cao, Y.L. and Dou, D.Q. Protective effect of ginsenoside-Re against cerebral ischemia/reperfusion damage in rats. Biol. Pharm. Bull. 29: 2502-2505, 2006.
22. Zhu, Y.Z., Huang, S.H., Tan, B.K., Sun, J., Whiteman, M. and Zhu, Y.C. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat. Prod. Rep. 21: 478-489, 2004.